INSIGHTS ON PHARMACEUTICAL INSPECTION
-
Ensuring Integrity: A Comprehensive Approach To CCI
Deterministic CCI testing ensures compliance in packaging. Learn how advanced methods like Vacuum Decay, HVLD, and Helium Leak Detection deliver results aligned with USP 1207 and global standards.
-
Unlock Smart Production: The Key Role Of Checkweighing
In today's fast-paced production, precision checkweighing is crucial. Discover how smart algorithms, real-time analysis, and automation optimize performance and minimize downtime.
-
Visual Inspection Of Advanced Therapy Medicinal Products
Discover how expert database systems for inspection defect management and control help cell and gene therapies meet the requirements of USP-790 to assure they are essentially free from particulate matter.
-
What Pharma And Biopharma Should Know About Container Closure Integrity
Explore high voltage leak detection, headspace analysis, and vacuum and pressure decay as applied in pharmaceutical manufacturing.
-
Empowering Glove Integrity Testing: Successful End User Training On The Esco IntelliGlove Tester (EIGT) In Bangladesh3/19/2026
Advanced wireless testing ensures glove and barrier integrity in sterile manufacturing. These tools support ISO compliance and Annex 1 standards to strengthen contamination control.
-
How Software-Enabled Manual Visual Inspection Can Boost Your ROI7/14/2025
Unlock hidden cost savings in pharma manufacturing. Learn how software-enabled manual visual inspection enhances efficiency, data integrity, and regulatory readiness without full automation's capital expense.
-
What Validation Really Means For Visual Inspection Programs5/8/2026
True validation requires documented proof that inspectors and methods consistently catch defects. Move beyond static SOPs to a state of continuous, data-backed compliance and audit readiness.
-
AI-Powered Visual Inspection: Boosting Efficiency In Production7/30/2025
Explore how AI is transforming visual inspection and gain a deep understanding of defect detection, real-time performance, and integration challenges.
-
Advancing Drug Product Quality Through AVI And Future-Ready Infrastructure9/5/2025
Automated visual inspection (AVI) combines robotics, precision imaging, and sophisticated defect-recognition software to provide a scalable solution for expanding pipelines and rises in production volumes.
PHARMACEUTICAL INSPECTION SOLUTIONS
-
Accelerate compliance with CCI methods that deliver reproducible results, ultra-sensitive leak detection, and global regulatory alignment to ensure product integrity while reducing risk and delays.
-
Helium leak detection (HeLD) is routinely used and widely accepted for applications that require the utmost leak sensitivity.
-
The VeriPac 410 utilizes a combination of vacuum decay technology and differential force measurement to identify defective packages. Multiple packages can be tested in a single test cycle, and the 410 identifies which package or cavity is defective.
-
The pharmaceutical industry continues to lead industries in terms of quality requirements and the value of data. The shift to more automated processes is less about the cost of human capital, but more about the pursuit of quality. The European Medicines Agency (EMA) updated Annex 1, driving for 100% inspection on fused containers and appropriate quality test measures for applications based on level of risk. The United States Pharmacopeia (USP) revamped Chapter 1207 on container closure integrity (CCI) to be prescriptive of deterministic technologies and encourages a deeper understanding of a container’s CCI requirements. The FDA continues to drive a ‘quality culture’ agenda versus a ‘compliance culture’, and the FDA has been explicitly targeting data integrity as a campaign for assuring quality. Every regulatory and guidance body is driving towards more reliable and accurate test methods.
-
Tyvek® gives the premium microbial barrier protection for sterilized medical instruments and pharmaceuticals. Apart from protecting the medical devices and pharmaceutical products from physical damages, medical and pharmaceutical packages also should provide an effective microbial barrier and help to maintain the sterility of the products. Bacteria and viruses with sizes varying from 0.002 to 100 microns are a constant threat to pharmaceuticals and medical devices which in turn can be hazardous to the patients.